People at ‘intermediate risk’ of heart disease with elevated hsCRP benefit from statin therapy
People at ‘intermediate risk’ of heart disease with elevated hsCRP benefit from statin therapy
People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein, a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels. Data indicates that people with only a 5 percent to 20 percent risk of having heart disease in the next 10 years, but who have high levels of …
Read more on EurekAlert!
Related posts:
- Am I at Risk for Heart Disease/ Heart Attack?
- “No study published over the last 20 years has reported a relationship between dietary cholesterol intake and heart disease risk in the general population.”
- 67 Percent of Heart Attacks in UAE Can Be Prevented by Lowering Cholesterol in People with Diabetes
- QuickMedical Praises New Study Linking High Cholesterol Levels to Increased Risk for Developing Alzheimer’s Disease or Vascular Dementia
- Heart Attack Prevention: Are you at risk for a heart attack